Nasdaq: CGEM
Cullinan Therapeutics insiders
The officers, directors and 10% owners of Cullinan Therapeutics, Inc. who hold the most stock, valued at the live CGEM price.
$9.07
CGEM today +$60K (+0.67%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 4
- Their CGEM stock
- $68.2M
- Market value
- $589M
- Held by ranked insiders
- 11.6%
Insiders by value of CGEM holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Vision Scs F2 | 10% owner | 3,331,071 | $30.2M | 5.13% | 3763rd |
| 2 | Morana Jovan-Embiricos | 10% owner | 3,274,554 | $29.7M | 5.04% | 3732nd |
| 3 | Ansbert Gadicke | 10% owner | 595,489 | $5.4M | 0.92% | 13301st |
| 4 | Biotechnology Value Trading Fund OS LP | Insider | 319,415 | $2.9M | 0.49% | Corporate |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Cullinan Therapeutics; see each profile for the filing.